Researchers turn to crowdfunding to develop Alzheimer's drug

Researchers turn to crowdfunding to develop Alzheimer's drug With money for basic and clinical research squeezed, some health researchers – including the UK team behind a dementia drug – are trying crowdfunding

Tests on a drug with the potential to stop Alzheimer’s in its tracks are being funded by raffles, pensioners’ donations and a sponsored walk – because the research team cannot find money for pre-clinical safety tests any other way.

The team of researchers led by Dr David Allsop at Lancaster University’s division of biomedicine and life sciences is running a crowdfunding campaign, Defying Dementia, to carry out the necessary preparatory testing on their drug in the belief they may be looking at a cure for the progressive brain disease. So far they have raised £52,000 towards their target of £165,000. Continue reading... The Guardian